View more on these topics

Charity attacks NU over stance on cancer

A leading cancer charity has hit out at an insurer&#39s decision to exclude a new bowel cancer treatment from its PMI policies and fears that others will follow suit.

In a letter seen by Money Marketing, Norwich Union Healthcare tells a consultant that it will not pay out for cancer patients who need a certain chemotherapy treatment.

The letter says that Cetuximab monotherapy, which is used to treat bowel cancer, is not eligible for benefit on NU Healthcare policies. The letter says the chemotherapy does not meet the provider&#39s definition of “treatment” for the purposes of the policy.

Cancer Bacup spokeswoman Jill Morrell says this is a worrying shift.

NU argues that the relatively new drug is not used to “cure” cancer as it does not kill cancer cells but to encourage long-term stabilisation of the disease.

Morrell says: ” This drug is not a palliative, it controls the development of cancer cells. It is a modern short-term treatment. At the very least, if insurers are not going to pay out for it they should make it clear from the outset.”

Recommended

&#39House prices grinding to a halt&#39 – Rightmove

The rise in house prices is grinding to a halt in the North and Northwest according to Rightmove, which looked at asking prices from August 14th to August 28th. Rightmove says national asking prices fell by 0.6 per cent or £1,217 in the last two weeks and puts the average property asking price at £191,118. […]

Like it or lump it

In a previous article, I raised the question of whether a section 32 contract is the ideal product to be in before A-Day (Money Marketing, July 29). The argument went that a blanket decision to move all individuals into a section 32 is not the panacea it has been made out to be. Rather than […]

Keydata fills income gap

Keydata has introduced a new issue of the extra income plan, a capital-protected bond linked to the performance of the FTSE 100 index for a term of five years. The bond, which is also available as an Isa and for Pep transfers, provides a choice of annual income at 6.25 per cent gross, quarterly income […]

Product Matters

This year will undoubtedly be one of the bestfor venture capital trusts for some time. A whole raft of existing and new names will be seeking funds as they capitalise on the higher popularity of VCTs due to increased tax rebates for investors. The fact that many new names will be entering the market brings […]

Inheritance tax and estate planning – exemptions and reliefs

By Kim Jarvis, technical manager with Canada Life’s ican Technical Services Team In this article we look at the main exemptions and reliefs that are available on death. Within the article, spouse also means civil partner.   Nil-rate band Under current rules, any part of the estate that falls within the available nil-rate band (NRB), […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment

    Close

    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm

    Email: customerservices@moneymarketing.com